跳至主要内容
临床试验/RBR-523wzcb
RBR-523wzcb进行中(未招募)未知

Effect of Docosahexaenoic Acid (DHA) supplementation on the incidence of Retinopathy of Prematurity

Secretaria Estadual da Saúde de Santa Catarina0 个研究点开始时间: 2023年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
0 至 33W(—)

入选标准

  • Premature babies with mothers older than 18 years of age; up to 33 gestational age; who were born at Maternidade Darcy Vargas from March 1 2020 to August 31 2022 whose mothers have signed the Free and Informed Consent Form

排除标准

  • Premature babies with congenital eye malformation; whose mothers have been supplemented with omega-3 and who have had infectious diseases

研究者

发起方
Secretaria Estadual da Saúde de Santa Catarina

相似试验